Annual EBIT
-$2.39 M
+$4.38 M+64.74%
December 31, 2023
Summary
- As of February 7, 2025, HROW annual earnings before interest & taxes is -$2.39 million, with the most recent change of +$4.38 million (+64.74%) on December 31, 2023.
- During the last 3 years, HROW annual EBIT has fallen by -$3.13 million (-418.98%).
- HROW annual EBIT is now -228.07% below its all-time high of $1.86 million, reached on December 31, 2021.
Performance
HROW EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$1.32 M
+$1.67 M+481.84%
September 30, 2024
Summary
- As of February 7, 2025, HROW quarterly earnings before interest & taxes is $1.32 million, with the most recent change of +$1.67 million (+481.84%) on September 30, 2024.
- Over the past year, HROW quarterly EBIT has dropped by -$1.57 million (-54.26%).
- HROW quarterly EBIT is now -88.90% below its all-time high of $11.94 million, reached on March 31, 2019.
Performance
HROW Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$11.73 M
-$1.57 M-15.47%
September 30, 2024
Summary
- As of February 7, 2025, HROW TTM earnings before interest & taxes is -$11.73 million, with the most recent change of -$1.57 million (-15.47%) on September 30, 2024.
- Over the past year, HROW TTM EBIT has dropped by -$16.82 million (-330.65%).
- HROW TTM EBIT is now -184.76% below its all-time high of $13.84 million, reached on March 31, 2021.
Performance
HROW TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
HROW EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +64.7% | -54.3% | -330.6% |
3 y3 years | -419.0% | +120.0% | -252.1% |
5 y5 years | +54.3% | -85.5% | -294.4% |
HROW EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -228.1% | +64.7% | -85.2% | +116.3% | -330.6% | at low |
5 y | 5-year | -228.1% | +64.7% | -85.5% | +110.7% | -184.8% | +53.2% |
alltime | all time | -228.1% | +84.7% | -88.9% | +110.7% | -184.8% | +53.2% |
Harrow Health EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $1.32 M(-481.8%) | -$11.73 M(+15.5%) |
Jun 2024 | - | -$347.00 K(-95.7%) | -$10.16 M(+21.6%) |
Mar 2024 | - | -$8.15 M(+78.8%) | -$8.35 M(+250.0%) |
Dec 2023 | -$2.39 M(-64.7%) | -$4.56 M(-257.4%) | -$2.39 M(-146.9%) |
Sep 2023 | - | $2.90 M(+98.4%) | $5.09 M(-308.4%) |
Jun 2023 | - | $1.46 M(-166.8%) | -$2.44 M(-70.6%) |
Mar 2023 | - | -$2.18 M(-175.0%) | -$8.30 M(+22.7%) |
Dec 2022 | -$6.77 M(-463.2%) | $2.91 M(-162.9%) | -$6.77 M(+814.5%) |
Sep 2022 | - | -$4.63 M(+5.1%) | -$740.00 K(-73.1%) |
Jun 2022 | - | -$4.41 M(+581.9%) | -$2.75 M(-665.5%) |
Mar 2022 | - | -$646.00 K(-107.2%) | $487.00 K(-73.9%) |
Dec 2021 | $1.86 M(+149.1%) | $8.94 M(-234.6%) | $1.86 M(-155.9%) |
Sep 2021 | - | -$6.64 M(+470.7%) | -$3.33 M(-126.8%) |
Jun 2021 | - | -$1.16 M(-259.5%) | $12.43 M(-10.2%) |
Mar 2021 | - | $730.00 K(-80.5%) | $13.84 M(+1750.4%) |
Dec 2020 | $748.00 K(-199.1%) | $3.75 M(-58.9%) | $748.00 K(-125.2%) |
Sep 2020 | - | $9.12 M(+3622.9%) | -$2.97 M(-87.1%) |
Jun 2020 | - | $245.00 K(-102.0%) | -$23.11 M(-7.8%) |
Mar 2020 | - | -$12.36 M(<-9900.0%) | -$25.05 M(+3218.4%) |
Dec 2019 | -$755.00 K(-85.5%) | $23.00 K(-100.2%) | -$755.00 K(-74.3%) |
Sep 2019 | - | -$11.01 M(+546.1%) | -$2.94 M(-139.6%) |
Jun 2019 | - | -$1.70 M(-114.3%) | $7.42 M(-12.7%) |
Mar 2019 | - | $11.94 M(-651.8%) | $8.50 M(-262.9%) |
Dec 2018 | -$5.22 M(-57.1%) | -$2.16 M(+233.3%) | -$5.22 M(+0.2%) |
Sep 2018 | - | -$649.00 K(+4.0%) | -$5.21 M(-28.9%) |
Jun 2018 | - | -$624.00 K(-65.0%) | -$7.32 M(-24.6%) |
Mar 2018 | - | -$1.78 M(-17.2%) | -$9.71 M(-20.1%) |
Dec 2017 | -$12.16 M(-21.9%) | -$2.15 M(-22.2%) | -$12.16 M(-10.0%) |
Sep 2017 | - | -$2.76 M(-8.4%) | -$13.52 M(-10.3%) |
Jun 2017 | - | -$3.02 M(-28.7%) | -$15.06 M(-6.2%) |
Mar 2017 | - | -$4.23 M(+20.6%) | -$16.06 M(+3.1%) |
Dec 2016 | -$15.58 M(+5.1%) | -$3.51 M(-18.6%) | -$15.58 M(-7.1%) |
Sep 2016 | - | -$4.31 M(+7.5%) | -$16.77 M(+4.9%) |
Jun 2016 | - | -$4.01 M(+6.8%) | -$15.99 M(+3.4%) |
Mar 2016 | - | -$3.75 M(-20.0%) | -$15.46 M(+4.3%) |
Dec 2015 | -$14.82 M | -$4.70 M(+33.0%) | -$14.82 M(+15.1%) |
Sep 2015 | - | -$3.53 M(+1.4%) | -$12.88 M(+9.1%) |
Jun 2015 | - | -$3.48 M(+11.7%) | -$11.81 M(+8.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2015 | - | -$3.12 M(+13.3%) | -$10.93 M(+7.7%) |
Dec 2014 | -$10.15 M(+32.8%) | -$2.75 M(+11.9%) | -$10.15 M(+9.4%) |
Sep 2014 | - | -$2.46 M(-5.5%) | -$9.28 M(+4.3%) |
Jun 2014 | - | -$2.60 M(+11.5%) | -$8.90 M(+4.5%) |
Mar 2014 | - | -$2.33 M(+24.1%) | -$8.51 M(+11.4%) |
Dec 2013 | -$7.64 M(+42.6%) | -$1.88 M(-9.4%) | -$7.64 M(+5.9%) |
Sep 2013 | - | -$2.08 M(-6.3%) | -$7.21 M(+13.0%) |
Jun 2013 | - | -$2.22 M(+51.4%) | -$6.38 M(+16.8%) |
Mar 2013 | - | -$1.47 M(+0.9%) | -$5.47 M(+2.0%) |
Dec 2012 | -$5.36 M(+509.7%) | -$1.45 M(+16.6%) | -$5.36 M(+28.9%) |
Sep 2012 | - | -$1.25 M(-4.3%) | -$4.16 M(+39.6%) |
Jun 2012 | - | -$1.30 M(-4.1%) | -$2.98 M(+63.4%) |
Mar 2012 | - | -$1.36 M(+437.0%) | -$1.82 M(+107.4%) |
Dec 2011 | -$878.90 K(-64.5%) | -$252.90 K(+280.3%) | -$879.00 K(-12.7%) |
Sep 2011 | - | -$66.50 K(-54.4%) | -$1.01 M(-39.6%) |
Jun 2011 | - | -$145.80 K(-64.8%) | -$1.67 M(-17.4%) |
Mar 2011 | - | -$413.80 K(+8.8%) | -$2.02 M(-18.5%) |
Dec 2010 | -$2.48 M(-45.6%) | -$380.50 K(-47.7%) | -$2.48 M(-13.5%) |
Sep 2010 | - | -$727.80 K(+46.5%) | -$2.86 M(-6.6%) |
Jun 2010 | - | -$496.80 K(-42.9%) | -$3.06 M(-19.3%) |
Mar 2010 | - | -$870.70 K(+13.7%) | -$3.80 M(-16.6%) |
Dec 2009 | -$4.55 M(+21.5%) | -$766.10 K(-17.6%) | -$4.55 M(-4.2%) |
Sep 2009 | - | -$929.20 K(-24.5%) | -$4.75 M(+2.0%) |
Jun 2009 | - | -$1.23 M(-24.4%) | -$4.66 M(-1.1%) |
Mar 2009 | - | -$1.63 M(+68.8%) | -$4.71 M(+25.7%) |
Dec 2008 | -$3.75 M(+31.0%) | -$964.40 K(+15.5%) | -$3.75 M(-13.6%) |
Sep 2008 | - | -$834.70 K(-34.8%) | -$4.34 M(+70.5%) |
Jun 2008 | - | -$1.28 M(+92.0%) | -$2.54 M(+101.3%) |
Mar 2008 | - | -$667.00 K(-57.1%) | -$1.26 M(+111.2%) |
Dec 2007 | -$2.86 M(>+9900.0%) | -$1.55 M(-260.3%) | -$598.10 K(-170.3%) |
Sep 2007 | - | $969.10 K(-9508.7%) | $851.00 K(-820.6%) |
Aug 2007 | - | -$10.30 K(+836.4%) | -$118.10 K(+2.3%) |
May 2007 | - | -$1100.00(-42.1%) | -$115.50 K(+1.0%) |
May 2007 | -$13.60 K(-70.6%) | - | - |
Feb 2007 | - | -$1900.00(-98.2%) | -$114.40 K(+1.7%) |
Nov 2006 | - | -$104.80 K(+1261.0%) | -$112.50 K(+1361.0%) |
Aug 2006 | - | -$7700.00 | -$7700.00 |
May 2006 | -$46.20 K | - | - |
FAQ
- What is Harrow Health annual earnings before interest & taxes?
- What is the all time high annual EBIT for Harrow Health?
- What is Harrow Health annual EBIT year-on-year change?
- What is Harrow Health quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Harrow Health?
- What is Harrow Health quarterly EBIT year-on-year change?
- What is Harrow Health TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Harrow Health?
- What is Harrow Health TTM EBIT year-on-year change?
What is Harrow Health annual earnings before interest & taxes?
The current annual EBIT of HROW is -$2.39 M
What is the all time high annual EBIT for Harrow Health?
Harrow Health all-time high annual earnings before interest & taxes is $1.86 M
What is Harrow Health annual EBIT year-on-year change?
Over the past year, HROW annual earnings before interest & taxes has changed by +$4.38 M (+64.74%)
What is Harrow Health quarterly earnings before interest & taxes?
The current quarterly EBIT of HROW is $1.32 M
What is the all time high quarterly EBIT for Harrow Health?
Harrow Health all-time high quarterly earnings before interest & taxes is $11.94 M
What is Harrow Health quarterly EBIT year-on-year change?
Over the past year, HROW quarterly earnings before interest & taxes has changed by -$1.57 M (-54.26%)
What is Harrow Health TTM earnings before interest & taxes?
The current TTM EBIT of HROW is -$11.73 M
What is the all time high TTM EBIT for Harrow Health?
Harrow Health all-time high TTM earnings before interest & taxes is $13.84 M
What is Harrow Health TTM EBIT year-on-year change?
Over the past year, HROW TTM earnings before interest & taxes has changed by -$16.82 M (-330.65%)